Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Alper Sonmez"'
Autor:
Alper Sonmez, Hani Sabbour, Akram Echtay, Abbas Mahdi Rahmah, Amani Matook Alhozali, Fahad Sulman alSabaan, Fares H. Haddad, Hinde Iraqi, Ibrahim Elebrashy, Samir N. Assaad, Zaheer Bayat, Zeynep Osar Siva, Mohamed Hassanein
Publikováno v:
Journal of Diabetes, Vol 14, Iss 5, Pp 315-333 (2022)
Abstract The upsurge of type 2 diabetes mellitus is a major public health concern in the Middle East and North Africa (MENA) and Africa (AFR) region, with cardiorenal complications (CRCs) being the predominant cause of premature morbidity and mortali
Externí odkaz:
https://doaj.org/article/5b13a0b65efb42018d34679902d42f2b
Autor:
Ibrahim Demirci, Cem Haymana, Burcu Candemir, Bagdagul Yuksel, Mithat Eser, Coskun Meric, Safak Akin, Nese Ersoz Gulcelik, Alper Sonmez
Publikováno v:
Archives of Endocrinology and Metabolism (2023)
ABSTRACT Objectives: This study aimed to investigate the triglyceride-glucose (TyG) index, which is a simple surrogate marker of insulin resistance that is associated with various cardiometabolic diseases, in patients with Klinefelter syndrome (KS).
Externí odkaz:
https://doaj.org/article/754cc722c4cf466487cd58a6d8a6ec94
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 15, Iss , Pp 200160- (2022)
Background: The prevalence of diabetes mellitus is growing worldwide, showing almost a 10-fold increase in the last five decades. Despite advances in the understanding of the disease mechanisms, preventive measures, and treatment options, morbidity a
Externí odkaz:
https://doaj.org/article/fe73d70821294e469a4a07c204f6dfb3
Autor:
Fahri Bayram, Alper Sonmez, Cem Haymana, Tevfik Sabuncu, Oguzhan Sitki Dizdar, Eren Gurkan, Ayse Kargili Carlioglu, Kemal Agbaht, Didem Ozdemir, Ibrahim Demirci, Cem Barcin, Serpil Salman, Tamer Tetiker, Mustafa Kemal Balci, Nur Kebapci, Canan Ersoy, Volkan Yumuk, Peter P. Toth, Ilhan Satman, TEMD Study Group
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background Attaining acceptable levels of LDL Cholesterol (LDL-C) significantly improves cardiovascular (CV) outcomes in patients with type 2 diabetes mellitus (T2DM). The LDL-C target attainment and the characteristics of patients attaining
Externí odkaz:
https://doaj.org/article/3bd78abe0da7469881d7892af599876c
Autor:
Rosaria Vincenza Giglio, Angelo Maria Patti, Ali Abbas Rizvi, Anca Panta Stoian, Marcello Ciaccio, Nikolaos Papanas, Andrej Janez, Alper Sonmez, Maciej Banach, Amirhossein Sahebkar, Manfredi Rizzo
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 291 (2023)
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) worldwide. Its pathogenesis encompasses functional alterations involving elevated intraglomerular and systemic pressure, increased activity of the renin-angiotensin syst
Externí odkaz:
https://doaj.org/article/9cee2cede4ae4fc289b7cc8f75a146c0
Autor:
Mirjana T. Macvanin, Manfredi Rizzo, Jelena Radovanovic, Alper Sonmez, Francesco Paneni, Esma R. Isenovic
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2970 (2022)
(1) Background: Obesity is closely connected to the pathophysiology of cardiovascular diseases (CVDs). Excess fat accumulation is associated with metabolic malfunctions that disrupt cardiovascular homeostasis by activating inflammatory processes that
Externí odkaz:
https://doaj.org/article/612b219ea0e646219239540cccf8d1b4
Autor:
Alper Sonmez, Volkan Yumuk, Cem Haymana, Ibrahim Demirci, Cem Barcin, Sinem Kıyıcı, Sibel Güldiken, Gonca Örük, Basak Ozgen Saydam, Süleyman Baldane, Faruk Kutlutürk, Ferit Kerim Küçükler, Oğuzhan Deyneli, Berrin Çetinarslan, Tevfik Sabuncu, Fahri Bayram, Ilhan Satman
Publikováno v:
Obesity Facts, Vol 12, Iss 2, Pp 167-178 (2019)
Background: Obesity is the main obstacle for metabolic control in patients with type 2 diabetes. Turkey has the highest prevalence of obesity and type 2 diabetes in Europe. The effect of obesity on the metabolic control, and the macro- and microvascu
Externí odkaz:
https://doaj.org/article/cefeda49f6d0418592bcaa9561f35097
Autor:
Jelena Vekic, Aleksandra Zeljkovic, Arrigo F. G. Cicero, Andrej Janez, Anca Pantea Stoian, Alper Sonmez, Manfredi Rizzo
Publikováno v:
Medicina, Vol 58, Iss 2, p 299 (2022)
Atherosclerosis is responsible for large cardiovascular mortality in many countries globally. It has been shown over the last decades that the reduction of atherosclerotic progression is a critical factor for preventing future cardiovascular events.
Externí odkaz:
https://doaj.org/article/e4a25e8132c14102bdcfa0de5aa61ee0
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 12, p 6627 (2021)
Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrome which can progress to cirrhosis, liver failure and hepatocellular carcinoma. However, the most common cause of mortality in people with NAFLD is not
Externí odkaz:
https://doaj.org/article/5ef1ffaa250c4ddcbfe52863e0997aa9
Autor:
Alper Sonmez, Teoman Dogru, Cemal Nuri Ercin, Halil Genc, Gurkan Celebi, Hasan Gurel, Serkan Tapan, Ali Fuat Cicek, Cem Barcin, Cem Haymana, Ali Kirik, Manfredi Rizzo
Publikováno v:
Metabolites, Vol 11, Iss 7, p 425 (2021)
Betatrophin, a liver hormone, regulates glucose and lipid metabolism. We investigated the betatrophin levels in nonalcoholic fatty liver disease (NAFLD) and searched for any relationship with histological severity and metabolic parameters. Fifty male
Externí odkaz:
https://doaj.org/article/48c5050598ba445da0600f62afc869a6